ArticleBMC proceedings2021

Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer - Proceedings from breast cancer expert group meeting.

Shaheenah Dawood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.